ProCE Banner Series

Advancing the Line with New Combination Therapies for Malignant Melanoma

Register now for the CME/ABIM MOC-certified interactive workshop series on new combination therapy strategies in advanced melanoma!

  AMA
Who Should Attend

The intended audience for this educational initiative includes oncologists and other clinicians involved in the treatment of patients with melanoma

All Events

Past Events

May

30

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Private Event, Royal Oak, Michigan

June

22

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

6:00 PM - 7:00 PM Pacific Time (PT)

Virtual

June

29

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

4:00 PM - 5:00 PM Central Time (CT)

Virtual

July

27

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

7:00 PM - 8:00 PM Eastern Time (ET)

In-personVirtual

Private Event | Host Group at Sevan, Oakland Gardens, New York

August

02

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma [Open Registration]

4:30 PM - 5:30 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group OK, Norman, Oklahoma

September

19

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

3:30 PM - 4:30 PM Mountain Time (MT)

Virtual

Private Event | Virtual Group NM, Rio Rancho, New Mexico

October

02

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma [Open Registration]

11:30 AM - 12:30 PM Eastern Time (ET)

In-personVirtual

CCO Simulcast | Host Group MD, Baltimore, Maryland

October

06

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

7:30 AM - 8:30 AM Eastern Time (ET)

Virtual

Private Event | Virtual Group NC, Hendersonville, North Carolina

October

12

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

7:30 AM - 8:30 AM Pacific Time (PT)

Virtual

Private Event | Virtual Group ID, Post Falls, Idaho

October

26

2023

Advancing the Line with New Combination Therapies for Malignant Melanoma

4:30 PM - 5:30 PM Eastern Time (ET)

Virtual

Private Event | Virtual Group NY, Brooklyn, New York

Faculty

ProCE Banner Faculty
C. Lance Cowey, MD

Medical Director
Division of Skin Malignancy Research and Treatment Center
Baylor-Sammons Cancer Center
Texas Oncology
Dallas, Texas

ProCE Banner Faculty
Pauline Funchain, MD

Melanoma & Cutaneous Oncology
Clinical Cancer Genetics
Division of Hematology/Oncology
Stanford University School of Medicine
Stanford, California

ProCE Banner Faculty
Evan J. Lipson, MD

Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

ProCE Banner Faculty
April Salama, MD

Associate Professor of Medicine
Division of Medical Oncology
Director, Melanoma Program
Duke Cancer Institute
Durham, North Carolina

ProCE Banner Faculty
Sarah Weiss, MD

Associate Professor of Medicine

Department of Medical Oncology

Director

Melanoma/Cutaneous Oncology Program

Rutgers Cancer Institute of New Jersey

New Brunswick, New Jersey

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, confidence, competence, and performance of learners in understanding and applying the latest science and clinical trial data on current and emerging melanoma combination therapies for the treatment of malignant melanoma. 

Target Audience
The intended audience for this educational initiative includes oncologists and other clinicians involved in the treatment of patients with melanoma 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate novel combination therapy regimens into the management of appropriate patients with previously untreated metastatic melanoma
  • Evaluate emerging combination regimens for the treatment of melanoma progressing on immune checkpoint inhibitors
  • Manage treatment-related adverse events in an evidence-based manner

Accreditation

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and Rockpointe. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit

USF Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information about accreditation of this activity, please email: cpdsupport@usf.edu

American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points and patient safety MOC credit in the American Board of Internal Medicine's (ABIM’s) Maintenance of Certification (MOC) program. It is USF Health’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants will earn MOC Points equivalent to the amount of CME credits claimed for the activity. USF Health will submit within 60 days the Diplomat’s MOC Points. No ABIM MOC Points certificates will be provided. Diplomats with questions regarding their Points, should contact USF Health at cpdsupport@usf.edu.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through USF Health's ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

Disclosure of Conflicts of Interest
USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant financial relationships are listed below. All individuals not listed have no relevant financial relationships.

Acknowledgement

Jointly provided by USF Health and Rockpointe

Supported by educational grants from Eisai Inc. and Merck Sharp & Dohme LLC